MicroTransponder

MicroTransponder is a medical device company transforming stroke care with the FDA-approved Vivistim® Paired VNS™ System. Vivistim is the first and only FDA-approved intervention clinically proven to help chronic ischemic stroke survivors regain significantly more upper extremity function. The system combines an implanted device with vagus nerve stimulation (VNS) during therapy, promoting neuroplasticity and improved outcomes for stroke survivors.

Funding Round: Series F

Funding Amount: $65M

Date: 12-Mar-2025

Investors: US Venture Partners (USVP), Osage University Partners, Action Potential Venture Capital, GPG Ventures, The Vertical Group, Exceller Hunt Ventures, Gilde Healthcare, Longitude Capital

Markets: Healthtech, Medical Devices

HQ: Austin, Texas, United States

Founded: 2007

Website: https://www.microtransponder.com/

LinkedIn: https://www.linkedin.com/company/microtransponder

Twitter: https://twitter.com/microtranspondr

Instagram:

Facebook: https://www.facebook.com/microtransponder

Crunchbase: https://www.crunchbase.com/organization/microtransponder

Pitchbook: https://pitchbook.com/profiles/company/53633-62